Skip to main content
. 2022 Jul 27;78(10):1647–1655. doi: 10.1007/s00228-022-03366-3

Fig. 4.

Fig. 4

Concern about the potential consequences of sharing personal information. Shown is the response distribution to a question worded as, “During your participation in clinical trials, you have consented to the disclosure of your personal data to third parties in anonymized form. How concerned are you about the following possible consequences of sharing anonymous clinical trial data?”